Clostridium Perfringens C,D Kb

11 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

8180.0%

Death Rate

Active Ingredients

Clostridium Perfringens C,D Kb

Administration Routes

SubcutaneousUnknown

Species Affected

Cattle 11

Most Affected Breeds

Cattle (other) 4

Aberdeen Angus 3

Crossbred Bovine/Cattle 2

Mixed (Cattle) 1

Red Angus 1

Most Reported Reactions

Death 8

Lack of efficacy - NOS 4

Anaphylaxis 2

Lethargy (see also Central nervous system depression in 'Neurological') 2

Anaphylactic-type reaction 2

Rumen acidosis 1

Malaise 1

INEFFECTIVE, WORMS NOS 1

INEFFECTIVE, ANTIBIOTIC 1

NT - Abnormal necropsy finding NOS 1

Found dead 1

Lack of efficacy (bacteria) - NOS 1

Outcome Breakdown

Died

9 (47.4%)

Recovered/Normal

4 (21.1%)

Outcome Unknown

4 (21.1%)

Ongoing

2 (10.5%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.